Physician profile
Patrick Lee
NPI 1164954723
$13,499.88
in general payments reported to CMS, 2019-2025
7 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $494 · 2022: $5,788 · 2023: $3,930 · 2024: $1,990 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,132 · Food and Beverage: $3,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,132.25 |
| Food and Beverage | $3,085.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $9,374.16 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $1,487.61 | 2021-2025 | Indigo System, Penumbra System, Ruby Coil |
| Boston Scientific Corporation | $1,360.08 | 2023-2025 | Obsidio, General - Embolics, Embold Fibered |
| Stryker Corporation | $814.06 | 2022-2025 | Augment Injectable, Spinejack, Optablate |
| Nevro Corp. | $253.26 | 2024 | Senza |
| Medtronic, INC. | $194.09 | 2021-2022 | |
| Cardiva Medical, INC. | $16.62 | 2024 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.